Database

Startups

Main Industry
Biotechnology
Main Product/Service
AcuSolutions’ Optical Section device acquires pathological images by scanning the fresh tissue samples directly and automatically, without traditional sample sectioning, H&E staining procedures. Therefore the frozen artifacts are avoided, and the accuracy is improved. The automation operation of the device refrain from the constraint of on-site man power needed. The acquired images are intrinsically digital. The pathologist can read the images remotely through the network and broaden the diagnosis service area.
Founded Year
2017
Unified Business No.
52585834
Status
Active
Number of Employees
0
Total Paid-in Capital
1,000,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
About the Company
We are a startup from Taiwan. Our members include top researchers in both engineering and medical fields. We are committed to solving various problems in today's medical technology, and look forward to improving medical quality.



More ↓

Similar Companies

BIOLEGEND TAIWAN INC.

1. Antibodies and Reagents
2. Apoptosis and Cell Health Reagents
3. Buffers and Chemical Probes
4. Clinical | Analyte Specific Reagents (ASR)
5. Isotype Controls
6. Magnetic Separation - MojoSort?
7. Non-Human Primate Antibodies
8. Recombinant Proteins, Cytokines, Growth Factors
9. SARS-CoV-2 Reagents
10. Soluble MHC ? Flex?T?
11. Ultra-LEAF? | GoInVivo? Antibodies
12. Cell-Vive? GMP Portfolio